Region: European Union

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2022

Obtaining patent protection for a polymorph in addition to a primary compound patent may be particularly advantageous, especially if filed successively, as the polymorph patent may add extra time to the patent protection for the modification of an approved drug or a clinical candidate.

18 August 2022

Despite the increasing attraction of the London courts, the real FRAND focus in Europe is likely to be on EU action which is promised by the end of the year

05 August 2022

The EUIPO has ruled that Lego’s brick design is solely dictated by technical function, but being part of a modular system saves it from invalidation. It remains to be seen whether other products will turn to the modular system exception.

27 July 2022

With no concrete American policy, the door is now open for the European Union to decide the future of FRAND licensing

20 July 2022

The first batch of judges for the court are also set to be appointed shortly, while an early 2023 launch date is now forecast

19 July 2022

In an exclusive IAM interview, Judge Florencio Molina López talks about his court’s approach to the Mobile World Congress as well as the country’s potential entry into the Unified Patent Court

18 July 2022

Life sciences companies in Europe are now operating under a regime in which many more patent extension rights are affected by exemptions

05 July 2022

Local IP professionals are hoping for a vote in early 2023 but may have to wait longer, while outcome is also uncertain

01 July 2022

Moves announced after consultation will affect copyright and database rights, but leave status quo in place for inventorship

29 June 2022

The refusal of a judge in Amsterdam to grant the US company relief covering Ireland, France and Germany does not indicate major change to the regime

28 June 2022